MOC
Available: 09/29/2026-09/28/2029
Format
Treatment for Tourette Syndrome
Course Description: This educational activity will include pharmacologic and behavioral therapy, including first-line treatment of Comprehensive Behavioral Intervention for Tics (CBIT). While 49%–59% of pediatricians and family physicians prescribe pharmacologics, many report discomfort doing so. Behavioral therapy, particularly CBIT, is often underutilized despite being effective.
Learning Objectives:
1. Describe the DSM-5-TR diagnostic criteria for Tourette Syndrome and other tic disorders.
2. Identify the primary evidence-based pharmacological and behavioral treatment strategies.
Co-Occurring Conditions with Tourette Syndrome
Course description: This educational activity examines the most common conditions that co-occur with Tourette Syndrome. It explains why these conditions are frequently seen together and how they relate to tics. Participants will learn evidence-based strategies for managing tics and associated conditions.
Learning Objectives:
1. Identify the most common co-occurring conditions in those with Tourette Syndrome and explain why those conditions are commonly seen together.
2. Apply evidence-based management strategies to tics and their most common co-occurring conditions.
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $200,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
Treatment for Tourette Syndrome
Co-Occurring Conditions with Tourette Syndrome
Reviewers (for both):
AAP Member Registration Fee: $0
Non-Member Registration Fee: $0
Enduring Materials
NAPNAP Contact Hours
MOC Part 2
AAPA Credit Hours
Physician - Tourette Syndrome: Treatment and Co-Occurring Conditions
The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AAP designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is approved for 1.00 points of MOC Part 2 credit by the American Board of Pediatrics through the AAP MOC Portfolio Program. All approved activities must be completed by the MOC Credit Approval End Date. All deadlines and MOC point values should be confirmed by checking the ABP Activity Catalog within each physician’s ABP Portfolio. Consult your ABP portfolio at www.abp.org for details about your specific certification requirements. For questions about how to access this activity, contact [email protected].
The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
PAs may claim a maximum of 1.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
This program is accredited for 1.00 NAPNAP CE contact hours of which 0.00 contain pharmacology (Rx) content, (0.00 related to psychopharmacology) (0.00 related to controlled substances), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines. The AAP is designated as Agency #A17. Upon completion of the program, each participant desiring NAPNAP contact hours must send a completed certificate of attendance to [email protected]. Payment of $15 for NAPNAP members and nonmembers is required via credit card for all NAPNAP contact hour requests. Keep this certificate for your records for six (6) years. Requests for duplicate certificates should be made to the AAP.
Recommended Browsers:
Recommended Browser Settings:
Price:: 0.00